Iris Healthcare is a scalable, personalized, virtual platform model specially designed for comprehensive ACP. Comprehensive ACP is a robust process designed to ensure that people receive medical care consistent with their values, goals, and preferences during serious and chronic illness by formally documenting those wishes in an advance directive. Despite robust literature demonstrating that participation in an ACP program can help improve patient health outcomes and lower unnecessary care utilization, thereby lowering costs, Medicare data reports that only about 2.8 percent of seniors end up having these discussions with their doctor. The acquisition follows a successful pilot program completed by the companies, which demonstrated better outcomes, higher patient satisfaction and lower costs when using Iris' service as well as significant improvements through use of Aledade's predictive algorithm and data, helping better identify patients who could most benefit from ACP.
"We are thrilled to be part of Aledade," said Steve Wardle, president and CEO of Iris Healthcare. "Aledade and Iris Healthcare share a vision for scaling value-based primary care in a way that benefits patients and physicians. Partnering with Aledade's seasoned leadership team strengthens our ability to ensure that patients receive the care they desire and avoid the care they don't."
Also joining Aledade as it enters this next phase of growth is a new member of its Board of Directors and Chair of its Audit Committee, Michelle Ryan, who recently retired as Treasurer of Johnson & Johnson after nearly 30 years of experience in health care leadership and finance. In her role as Treasurer, Michelle managed key relationships with external partners such as credit rating agencies and investment banks while also providing strategic financial support to acquisitions, divestitures, and licenses. At J&J, Michelle previously served as VP of Finance and CFO of the Global Consumer Group, VP of Finance and CFO of America's Pharmaceuticals, and VP of Finance and CFO Biotechnology, Immunology & Oncology.
About Aledade
Founded in 2014, Aledade is the leading physician enablement company helping independent practices, health centers, and clinics deliver better care to their patients and thrive in value-based care. Through its proven, scalable model, which includes cutting-edge data analytics, user-friendly guided workflows, regulatory expertise, strong payer relationships, and integrated care solutions delivered through Aledade Care Solutions, Aledade empowers physicians to succeed financially by keeping people healthy. Together with more than 1,000 practices in 37 states, Aledade shares in the risk and reward across more than 140 value-based contracts representing more than 1.7 million patient lives under management.
Back to HCB News
